Friday , February 27 2026
Home / Media OutReach / Vetter establishes office in China to better serve the needs of its growing customer base worldwide

Vetter establishes office in China to better serve the needs of its growing customer base worldwide

Additional company office in the Asia Pacific region will showcase Vetter’s expertise and help build and strengthen its business network in China

  • New office underscores importance of Chinese market
  • Physical presence promotes
    development of new business in China
  • Comprehensive service portfolio
    supports domestic companies in accessing the 
    global market place




SHANGHAI, CHINA AND RAVENSBURG, GERMANY – Media
OutReach
 – 8 March 2021 -
Vetter, one of the global leaders in prefilled drug-delivery
systems, today announced the opening of a new business entity in Shanghai, China.
The new office, now its fourth in the Asia
Pacific (APAC) region
,
will help increase the visibility of Vetter’s presence in China and underlines its
importance as an important strategic market to Vetter. Thus, the office will
support customer relations and aid in the development of new business. As the
second largest pharmaceutical market and one of the largest in sales growth
rate worldwide, China offers a promising injectable pipeline and allows the
Contract Development and Manufacturing Organization (CDMO) to offer support to domestic
companies that plan on bringing their molecules to the global market. As a strategic partner, Vetter
supports its worldwide customer base through every phase of their injectable
drug product’s lifecycle, from early development
activities

to commercial supply up to lifecycle initiatives.


Vetter’s
new office underscores the importance of the Chinese market for the
pharmaceutical service provider. Oskar
Gold, Chervee Ho, and Jason Zhong (from left to right) act as key contacts.


Source: Vetter Pharma International GmbH




“We are convinced that our continued
investment in the Asia Pacific region will significantly contribute to our
future global growth,” explained Vetter Managing Director Peter Soelkner. “With
an increased share of Asian firms among the Top 50 Pharma companies worldwide over
the last several years, our mission is to service the needs of our global customer
base, of course including Asia, in the best-possible way.” Oskar Gold, Vetter’s
Senior Vice President for Asia Pacific/Emerging Global Markets outlined the
initiative: “Our presence in China demonstrates our dedication in one of the
most important markets of the APAC region and will help to increase the awareness
of Vetter’s services by presenting our expertise and market position onsite.” The
office is staffed by Mr. Jason Zhong, who assumes the position of Business
Development Manager China. As the first member of the new team in China,

Mr. Zhong will lead Vetter’s business activities reporting to Ms. Chervee Ho,
who is Vetter’s Director Key Account Management Asia Pacific, based in
Singapore.


 


The new office, located in Puxi,
Shanghai, is strategically positioned on Nanjing Road West in the heart of the
city’s Central Business District. Its creation follows Vetter’s business
development activities in its APAC regional office in Singapore, as well as in
its sales offices in Japan and South Korea, further strengthening its
footprint in the Asia Pacific region.


 


Find
the Vetter press kit and more bac
kground information here.



Source link

About admin

Check Also

China’s Dairy Serves Overseas Winter Olympics for the First Time Mengniu’s “World-Class Quality” Nourishes Global Athletes’ Drive to Excel

MILAN, ITALY – Media OutReach Newswire – 25 February 2026 – From February 7 to …

Leave a Reply

Your email address will not be published.